socalTECH

DECEMBER 15, 2020

Los Angeles-based life sciences investor Westlake Village BioPartners announced today that it has raised two new venture capital funds, worth a total of $500M, for its investments in biotech companies. The venture investor says it has now raised more than $820M in total for its investments. READ MORE>>.

Westlake Village 113

Westlake Village Funding Incubator San Diego 113

Xconomy

SEPTEMBER 5, 2018

Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital.

Westlake Village 73

Westlake Village Los Angeles Angel Venture Capital 73

Xconomy

JANUARY 27, 2020

By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital. Cancer drug developer Black Diamond filed IPO paperwork with regulators on Jan. 7 detailing its plans to use to the cash to finance Phase 1/2.

Westlake Village 109

Westlake Village Class Research Capital 109

socalTECH

JULY 7, 2010

One complaint we sometimes hear from venture capitalists visiting Southern California for the first time, is the difficulty of finding experienced entrepreneurs and executives. Row 44 / John Guidon / Westlake Village - Guidon sold his last firm--Comcore Semiconductor--back in 1998 to National Semiconductor, for a substantial gain.

Southern California 228

Southern California Entrepreneur SoCal Mahalo 228

Xconomy

SEPTEMBER 7, 2018

If you’re still recovering from a Labor Day hangover or busy searching for the identity of the anonymous writer of the anti-Trump op-ed for the New York Times, you may have missed a few biomedical firsts.

Westlake Village 55

Westlake Village Develop Development San Diego 55